Document is current

Article History

Received: 13 May 2025

Accepted: 9 August 2025

First Online: 30 August 2025

Declarations

:

: EAM reports compensated service on scientific advisory boards for AstraZeneca, BioNTech, Merck and Moderna; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speakers honoraria and travel support from Merck Sharp & Dohme; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. EAM also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. TAK reports speaker honoraria for Exact Sciences, compensated service on the FES Steering Committee for GE Healthcare, compensated service for advisory board role for Veracyte, and compensated service as faculty for PrecisCa cancer information service. The remaining authors have no conflicts of interest to disclose.

: The conduct of this review was guided by the JBI Manual for Evidence and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. A protocol for this study is registered with PROSPERO, CRD42024551909. As this study leveraged publicly available data sources, no institutional review board approval was necessary.

: N/A